About
Awards
History
Leadership
Board of Directors
Investors and Partners
Pipeline
Cefepime-Taniborbactam
Ceftibuten-Ledaborbactam Etzadroxil
PBP Inhibitor
Publications
Manuscripts
Conference Presentations
News & Events
Press Releases
In the News
Events
Careers
Open Positions
#venatorxcares
Contact
Publications
Publications
Manuscripts
Conference Presentations
Manuscripts
Examining the activity of cefepime-taniborbactam against
Burkholderia cepacia
complex and
Burkholderia gladioli
isolated from cystic fibrosis patients in the United States
Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-
β
-Lactamase-Positive Clinical Isolates of
Enterobacterales
from a 2018–2020 Global Surveillance Collection
MORE MANUSCRIPTS
Conference Presentations
Susceptibility Profiles of Baseline Gram-negative Pathogens from CERTAIN-1, a Phase 3 Study comparing Cefepime-taniborbactam to Meropenem in Adultswith Complicated Urinary Tract Infection (cUTI)
Validation of Cefepime-Taniborbactam MIC Antimicrobial Susceptibility Test for MicroScan Dried Gram-Negative MIC Panels from a Multicenter Assessment of Enterobacterales and
Pseudomonas aeruginosa
Activity of Cefepime-Taniborbactam (FTB) Against Enterobacterales and P. aeruginosa Collected Globally in 2018-2021 Stratified by β-lactamase Carriage
Antimicrobial Activity of Cefepime in Combination with Taniborbactam Against Resistant Clinical Isolates of Enterobacterales from 2018-2021 Global Surveillance
MORE CONFERENCE PRESENTATIONS
You are using a browser that is not supported. Please consider changing your browser
